Related Experiment Video
Updated: Oct 10, 2025

08:46
Author Spotlight: Investigating Bacteriophage-Induced Immune Responses in Gnotobiotic Mice
Published on: January 26, 2024
2.0K
Naturally-occurring and cultured bacteriophages in human therapy
A K Kiani1, K Anpilogov, K Dhuli
1MAGI EUREGIO, Bolzano, Italy. stefano.paolacci@assomagi.org.
European Review for Medical and Pharmacological Sciences
|December 10, 2021
Summary
Bacteriophages offer a promising alternative to antibiotics for treating bacterial infections and improving gut health. These viruses can specifically target pathogens and may be developed into effective therapeutics or food supplements.
Area of Science:
- Microbiology
- Virology
- Biotechnology
Background:
- Antibiotic resistance is a growing global health concern, necessitating novel therapeutic strategies.
- Bacteriophages present a specific, non-antibiotic alternative for combating bacterial infections.
- Phage therapy offers advantages such as specificity and minimal impact on beneficial gut microbiota.
Purpose of the Study:
- To highlight the significance of developing techniques for utilizing bacteriophages.
- To explore the potential of bacteriophages as therapeutic agents.
- To investigate the application of bacteriophages as food supplements.
Main Methods:
- Literature search of the PubMed database.
- Keywords used included 'bacteriophage' and 'human therapy', and 'natural bacteriophage' and 'application'.
Main Results:
- Phage therapy is a viable alternative to antibiotics, targeting specific pathogens without harming the human microbiota.
- Bacteriophages can be administered via topical, oral, or intravenous routes.
- Combining phage therapy with antibiotics can enhance treatment efficacy for bacterial infections, with clinical trials showing promising results.
Conclusions:
- Phage therapy is poised to become a key therapeutic strategy for bacterial infections.
- Bacteriophage-containing supplements could be developed to modulate gut microbiota and combat pathogens.
- The Caudovirales order, particularly Siphoviridae and Myoviridae families, shows significant potential for these applications.
More Related Videos
Related Concept Videos
Lytic Cycle of Bacteriophages
72.8K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
72.8K
DNA Bacteriophages
235
Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
235
Lysogenic Cycle of Bacteriophages
63.9K
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
63.9K
Microorganisms in Medicine and Therapeutics
463
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
463
Viral Replication: Lysogenic Cycle
418
The lysogenic cycle is a crucial viral replication strategy that allows bacteriophages to persist within host cells without immediately destroying them. This process is primarily observed in temperate phages, such as bacteriophage lambda (λ), which infects Escherichia coli. The cycle allows the viral genome to persist across bacterial generations while keeping host cells viable.Integration of the Viral GenomeUpon infection, bacteriophage lambda attaches to the bacterial surface and injects...
418
Viral Replication: Lytic Cycle
433
Bacteriophages, or phages, are viruses that specifically infect bacteria. Among them, T-even bacteriophages, such as T4, exhibit a well-characterized lytic replication cycle in Escherichia coli (E. coli). This process ensures the rapid proliferation of the virus while ultimately leading to the destruction of the bacterial host.Attachment and DNA InjectionThe infection process begins with the recognition and binding of the T4 phage to the E. coli cell surface. Tail fibers of the phage...
433

